# Guangdong CR Shunfeng Pharmaceutical Co., Ltd. – FDA Inspection, Jul 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/guangdong-cr-shunfeng-pharmaceutical-co-ltd/abf77e2a-18d3-4e22-b93d-449c5e029cb1
Source feed: FDA_Inspections

> FDA inspection 1021285 of Guangdong CR Shunfeng Pharmaceutical Co., Ltd., July 14, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1021285
- Company Name: Guangdong CR Shunfeng Pharmaceutical Co., Ltd.
- Inspection Date: 2017-07-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/daveta-l-bailey/b3c06872-638b-4c47-9539-a93b819be23f)
- [FDA Associated Person](https://www.keypedia.com/people/tajah-l-blackburn/27b25d9d-3186-4b3a-a511-2f693d3c889a)

Company: https://www.keypedia.com/companies/guangdong-cr-shunfeng-pharmaceutical-co-ltd/c6ca11ff-d268-42e3-95f0-835c036a0488

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c